Pathogenesis of non-alcoholic fatty liver disease is centered on increased hepatic lipogenesis and decreased hepatic lipolysis in the setting of hepatic and systemic insulin resistance. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.